Medical imaging software developer ISG Technologies has named Max Rutherford president and COO of the Mississauga, Ontario, company. Rutherford fills a position once held by Thomas Cafarella, the former ISG executive who participated in a takeover bid
Medical imaging software developer ISG Technologies has named Max Rutherford president and COO of the Mississauga, Ontario, company. Rutherford fills a position once held by Thomas Cafarella, the former ISG executive who participated in a takeover bid for ISG after he was released from the company last year (SCAN 1/8/97).
Rutherford comes to ISG from CAE Electronics, a flight-simulator company, where his last two posts were vice president of business development and vice president of engineering. ISG got its start as a flight-simulator developer before shifting to medical imaging.
Rutherford will be responsible for ISG's business units and operations groups. He will report to Dr. Michael Greenberg, who remains ISG's chairman and CEO.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.